: The management of older patients with chronic primary immune thrombocytopenia (ITP) is still very challenging because of the fragility of older patients who frequently have severe comorbidities and/or disabilities. Corticosteroid-based first-line therapies fail in most of the cases and patients require a second-line treatment, choosing between rituximab, thrombopoietin-receptor agonists and splenectomy. The choice of the best treatment in elderly patients is a compromise between effectiveness and safety and laparoscopic splenectomy may be a good option with a complete remission rate of 67% at 60 months. But relapse and complication rates remain higher than in younger splenectomized ITP patients because elderly patients undergo splenectomy with unfavorable conditions (age >60 year-old, presence of comorbidities, or multiple previous treatments) which negatively influence the outcome, regardless the hematological response. For these reasons, a good management of concomitant diseases and the option to not use the splenectomy as the last possible treatment could improve the outcome of old splenectomized patients.

Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia / Giudice, V.; Rosamilio, Rosa; Serio, B.; Di Crescenzo, R. M.; Rossi, F.; De Paulis, A.; Pilone, V.; Selleri, C.. - In: OPEN MEDICINE. - ISSN 2391-5463. - 11:1(2016), pp. 361-368. [10.1515/med-2016-0066]

Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia

Rosamilio R.;Serio B.;Di Crescenzo R. M.;De Paulis A.;Pilone V.;Selleri C.
2016

Abstract

: The management of older patients with chronic primary immune thrombocytopenia (ITP) is still very challenging because of the fragility of older patients who frequently have severe comorbidities and/or disabilities. Corticosteroid-based first-line therapies fail in most of the cases and patients require a second-line treatment, choosing between rituximab, thrombopoietin-receptor agonists and splenectomy. The choice of the best treatment in elderly patients is a compromise between effectiveness and safety and laparoscopic splenectomy may be a good option with a complete remission rate of 67% at 60 months. But relapse and complication rates remain higher than in younger splenectomized ITP patients because elderly patients undergo splenectomy with unfavorable conditions (age >60 year-old, presence of comorbidities, or multiple previous treatments) which negatively influence the outcome, regardless the hematological response. For these reasons, a good management of concomitant diseases and the option to not use the splenectomy as the last possible treatment could improve the outcome of old splenectomized patients.
2016
Role of Laparoscopic Splenectomy in Elderly Immune Thrombocytopenia / Giudice, V.; Rosamilio, Rosa; Serio, B.; Di Crescenzo, R. M.; Rossi, F.; De Paulis, A.; Pilone, V.; Selleri, C.. - In: OPEN MEDICINE. - ISSN 2391-5463. - 11:1(2016), pp. 361-368. [10.1515/med-2016-0066]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/933225
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 4
  • ???jsp.display-item.citation.isi??? ND
social impact